| ∆Ψm | membrane potential |
| 11-Deo-GA | 11-deoxy-glycyrrhetinic acid |
| 3-Ace-GA | C3-acetylated glycyrrhetinic acid |
| 3-O-gluc-GA | glycyrrhizic acid |
| 5-FU | 5-fluorouracil |
| ADE | adenine |
| AGP | andrographolide |
| aHSCs | activated HSCs |
| APDES | 3-(ethoxydimethylsilyl)propylamine |
| APS | Angelica sinensis polysaccharide |
| ASGP-R | asialoglycoprotein receptor |
| ART | artesunate |
| ATP | adenosine triphosphate |
| Bcl-2 | B-cell lymphoma 2 |
| CA4P | combretastatin A4 phosphate |
| CAPS | capsaicin |
| CMC | carboxymethyl chitosan |
| CPT | camptothecin |
| CS | chitosan |
| CUR | curcumin |
| CYP | cytochrome P450 |
| Cyt c | cytochrome c |
| DDS | drug delivery system |
| DEN | diethylnitrosamine |
| DiR | 3′-tetramethylindotricarbocyanine iodide |
| DOX | doxorubicin |
| DSGPE | 1,2-distearyl-sn-glycero-3-phosphoethanolamine |
| DSPE | distearoyl-phosphatidylethanolamine |
| DTX | docetaxel |
| EGF-R | epidermal growth factor receptor |
| EMA | European Medicines Agency |
| EPR | enhanced permeation and retention effect |
| ERK | extracellular signal-regulated kinase |
| FA-R | folate receptor |
| FDA | Food and Drug Administration |
| FITC | fluorescein isothiocyanate |
| Fmoc | 9-fluorenylmethyloxycarbonyl |
| GA | glycyrrhetinic acid |
| Gal | galactose |
| Gal-β(1–3)GalNA | β-d-galactosyl-(1–3)-N-acetyl-d-galactosamine |
| GH | GA modified HA |
| GHH | GA-HA-Histidine |
| GL-R | glycyrrhizin receptor |
| GO | graphene oxide |
| GR | galactose receptor |
| HA | hyaluronic acid |
| HA-R | hyaluronan receptor |
| HBA | 4-hydrazinobenzoic |
| HCC | hepatocellular carcinoma |
| HSCs | hepatic stellate cells |
| HZ | hydrazone |
| IP | intraperitoneal |
| IV | intravenous |
| LA | lactobionic acid |
| LMWH | low molecular weight |
| LRH-1 | liver receptor homolog 1 |
| LYVE-1 | lymphatic vessel endothelial hyaluronan receptor 1 |
| m-HSC | mouse hepatic stellate cell |
| MDR | multidrug resistant |
| MEK | mitogen-activated protein/extracellular signal-regulated kinase |
| MMP | matrix metalloproteinase |
| MOFs | metal-organic frameworks |
| MPT | mitochondrial permeability transition |
| mPEG | polyethylene glycol methyl ether |
| mTOR | mechanistic target of rapamycin |
| MR | mannose receptor |
| MSN | mesoporous silica nanoparticle |
| MWCNTs | multi-walled carbon nanotubes |
| NCTD | norcantharidin |
| NGO | nano-graphene oxide |
| NIR | near-infrared |
| NK-1R | neurokinin-1 receptor |
| NMOFs | nano-sized metal-organic frameworks |
| NP | nanoparticle |
| OX | oxaliplatin |
| PAK1 | P21-activated kinase 1 |
| PAMAM | poly(amidoamine) |
| PCL | poly-ε-caprolactone |
| PCNA | Proliferating Cell Nuclear Antigen |
| PDT | photodynamic therapy |
| PEG | polyethylene glycol |
| PEG2000 | polyethylene glycol 2000 |
| PEI | polyethylenimine |
| PHA | pheophorbide A |
| PHIS | poly(l-histidine) |
| PI3K | phosphatidyl Inositol 3-kinase |
| PLA | polylactic acid |
| PLGA | poly(d,l-lactide-co-glycolide) |
| PNA | peanut agglutinin |
| PPI | polypropylene imine |
| PS | photosensitizers |
| PTX | paclitaxel |
| RBCm | red blood cell membranes |
| ROS | reactive oxygen species |
| SC | subcutaneous |
| SH | sulfhydryl group |
| sHA | sulfated hyaluronic acid |
| shAkt1 | shRNA targeting Akt1 |
| shRNA | short/small hairpin RNA |
| siPAK1 | siRNA-targeting P21-activated kinase 1 |
| SiPC | silicon phthalocyanine |
| siRNA | short interfering RNA |
| SP | substance P |
| SS | disulfide |
| TDDS | targeted drug delivery system |
| TGF-β | transforming growth factor-β |
| TPP | tetraphenylporphyrin |
| UGTs | uridine 5’-diphospho-glucuronosyltransferases |
| VEGFa | vascular endothelial growth factor a |
| WG | wogonin |